{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:04:38Z","timestamp":1793664278398,"version":"4.5.1"},"reference-count":38,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["203856"],"award-info":[{"award-number":["203856"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Albuminuria is associated with an increased risk of cardiovascular and kidney events. Sodium glucose co\u2010transporter 2 inhibitors (\n                      <jats:styled-content style=\"fixed-case\">SGLT2i<\/jats:styled-content>\n                      ) reduce albuminuria and improve kidney outcomes in patients with albuminuric chronic kidney disease (\n                      <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n                      ). Patients with low\u2010 or without albuminuria have been underrepresented in randomised clinical trials (\n                      <jats:styled-content style=\"fixed-case\">RCTs<\/jats:styled-content>\n                      ), and the effects of\n                      <jats:styled-content style=\"fixed-case\">SGLT2i<\/jats:styled-content>\n                      on cardiovascular and kidney outcomes across the full range of albuminuria require further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      To study the effects of\n                      <jats:styled-content style=\"fixed-case\">SGLT2i<\/jats:styled-content>\n                      on kidney and cardiovascular outcomes across albuminuria levels in populations with different cardiovascular\u2013kidney\u2013metabolic (\n                      <jats:styled-content style=\"fixed-case\">CKM<\/jats:styled-content>\n                      ) risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Individual\u2010patient data pooled analysis of\n                      <jats:styled-content style=\"fixed-case\">RCTs<\/jats:styled-content>\n                      across the\n                      <jats:styled-content style=\"fixed-case\">CKM<\/jats:styled-content>\n                      spectrum. Outcomes were studied across urinary albumin\u2010to\u2010creatinine ratio (\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      ) both as categorical and continuous variables using survival and mixed effects models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of\u200926\u2009750 patients were included. The median (pct\n                      <jats:sub>25\u201075<\/jats:sub>\n                      ) baseline\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      was 28 (8\u2013240) mg\/g: 13\u2009669 (51.1%) had\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      &lt;30\u2009mg\/g, 6904 (25.8%)\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      30\u2013300\u2009mg\/g, and 6177 (23.1%)\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      &gt;300\u2009mg\/g. Compared to patients with lower\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      , those with higher\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      were younger, with a more frequent history of hypertension, diabetes, and obesity, and lower\n                      <jats:styled-content style=\"fixed-case\">eGFR<\/jats:styled-content>\n                      .\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      was linearly associated with kidney and cardiovascular outcomes as well as mortality. Compared to placebo,\n                      <jats:styled-content style=\"fixed-case\">SGLT2i<\/jats:styled-content>\n                      reduced the risk of kidney events,\n                      <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\n                      hospitalisations, atherothrombotic events, cardiovascular and all\u2010cause mortality across the full\n                      <jats:styled-content style=\"fixed-case\">UACR<\/jats:styled-content>\n                      spectrum (Pinteraction &gt;0.1 for all outcomes). Compared to placebo,\n                      <jats:styled-content style=\"fixed-case\">SGLT2i<\/jats:styled-content>\n                      reduced albuminuria levels by 13%, on average:\n                      <jats:styled-content style=\"fixed-case\">gMratio<\/jats:styled-content>\n                      0.87, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      0.85\u20130.88,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Higher albuminuria was associated with an increased risk of cardiovascular and kidney outcomes.\n                      <jats:styled-content style=\"fixed-case\">SGLT2i<\/jats:styled-content>\n                      improved cardiovascular and kidney outcomes across the full range of albuminuria, including normo\u2010albuminuria.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.70289","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T09:25:57Z","timestamp":1762766757000},"page":"1105-1115","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of\n                    <scp>SGLT2<\/scp>\n                    inhibitors across the spectrum of albuminuria in cardiovascular\u2013kidney\u2013metabolic conditions: A pooled analysis of randomised trials"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"first","affiliation":[{"name":"RISE\u2010Health, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina Universidade do Porto  Porto Portugal"},{"name":"Universit\u00e9 de Lorraine, INSERM, Centre d'Investigations Cliniques, CHRU de Nancy, Inserm and INI\u2010CRCT (Cardiovascular and Renal Clinical Trialists) F\u2010CRIN Network  Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[{"name":"RISE\u2010Health, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina Universidade do Porto  Porto Portugal"},{"name":"Servi\u00e7o de Medicina Interna Unidade Local de Sa\u00fade S\u00e3o Jo\u00e3o  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK) of German Heart Center Charit\u00e9, German Centre for Cardiovascular Research (DZHK) partner site Berlin Charit\u00e9 Universit\u00e4tsmedizin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7683-4720","authenticated-orcid":false,"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Research Institute, Dallas, TX and University of Mississippi  Jackson Mississippi USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens School of Medicine Athens University Hospital Attikon  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-8330","authenticated-orcid":false,"given":"Abhinav","family":"Sharma","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre McGill University  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vasques\u2010N\u00f3voa","sequence":"additional","affiliation":[{"name":"RISE\u2010Health, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina Universidade do Porto  Porto Portugal"},{"name":"Servi\u00e7o de Medicina Interna Unidade Local de Sa\u00fade S\u00e3o Jo\u00e3o  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-3941","authenticated-orcid":false,"given":"Lu\u00eds","family":"Mendon\u00e7a","sequence":"additional","affiliation":[{"name":"RISE\u2010Health, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina Universidade do Porto  Porto Portugal"},{"name":"Servi\u00e7o de Nefrologia Unidade Local de Sa\u00fade S\u00e3o Jo\u00e3o  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[{"name":"RISE\u2010Health, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina Universidade do Porto  Porto Portugal"},{"name":"Servi\u00e7o de Endocrinologia Unidade Local de Sa\u00fade S\u00e3o Jo\u00e3o  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[{"name":"Baylor University Medical Center  Dallas Texas USA"},{"name":"Imperial College  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, INSERM, Centre d'Investigations Cliniques, CHRU de Nancy, Inserm and INI\u2010CRCT (Cardiovascular and Renal Clinical Trialists) F\u2010CRIN Network  Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000533223"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000541686"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12654"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213\u20108587(21)00243\u20106"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213\u20108587(17)30182\u20101"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213\u20108587(19)30256\u20106"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(18)32590\u2010x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010019\u201049525\u2010y"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.2924"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2025.102514"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000877"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.08.024"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab096"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1596"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107038"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475\u20102840\u201013\u2010102"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12829"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000484633"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.022"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557\u2010020\u201007035\u20104"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac528"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.105.538132"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(12)61350\u20106"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.037"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2410659"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-10-200905190-00014"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107038"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2334"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2112411"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.050391"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.4210"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.05.010"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv124"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.70289","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/full-xml\/10.1111\/dom.70289","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.70289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:47:47Z","timestamp":1769719667000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.70289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1111\/dom.70289"],"URL":"https:\/\/doi.org\/10.1111\/dom.70289","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.70289\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70289\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70289\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70289\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70289\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70289\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"2025-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}